A2A Pharmaceuticals, Inc. - 31 May 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Issuer symbol
BMEA
Transactions as of
31 May 2023
Net transactions value
-$4,263,915
Form type
4
Filing time
02 Jun 2023, 17:00:32 UTC
Previous filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale $2,535,750 -75,000 -2.1% $33.81 3,550,000 31 May 2023 Direct F1
transaction BMEA Common Stock Sale $1,728,165 -50,000 -1.4% $34.56 3,500,000 01 Jun 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

A2A Pharmaceuticals, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request.
F2 A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request.